신풍제약

019170KOSPI

57.7 / 100

Reference Date: 2026-09-08

Financial Score15.0 / 40

News Sentiment17.7 / 25

Momentum15.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Surged 16.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Shinpoong Pharmaceutical is enhancing its competitiveness in the highly competitive domestic pharmaceutical market through global new drug development, improved generics, and first-generic launches, while focusing investments on high-profit products to improve profitability. Although sales increased by approximately 10.42% compared to the previous period, the company still recorded an operating loss due to ongoing R&D expenses.

Number of Employees

792people

Average Salary

77.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

61.36Industry Average 15.000.0Point

4.1x industry avg (risky)

PBR

1.90Industry Average 1.201.0Point

1.6x industry avg (risky)

ROE

3.17Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

5.48Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲8.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲113.3% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -7.2% (improving, 3yr)

Detailed News Sentiment

12 totalPositive 6Neutral 4Negative 2Average Sentiment Score 70.8

Neutral
국부유출·국민 부담 우려 때문에 민원?…업계 “유출 우려 없고 렉키.....
News discusses regulatory concerns without direct impact on 신풍제약's stock performance.
Neutral
서울대 창업결선 '넥스트 SNU 크라운'… 뇌과학 AI '리소리우스' ...
기사는 서울대학교 창업 경진대회와 관련된 스타트업 정보를 제공하지만, 신풍제약과 직접적인 연관성이 없다.
Negative
美 연준 의장 매파 발언에 코스피 2% 하락
코스피 하락으로 신풍제약 주가도 부정적 영향을 받음.

Detailed Momentum

52-week position3.0Point

52w lower range (30%)

Current 9,820Won52-week high 15,69052-week low 7,210

1-month return6.0Point

1m +16.08% (strong rise)

Volume trend6.0Point

Volume surge

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14